U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


SCHMIDT ERIC THOMAS (0001754403)
Mailing Address
C/O ALLOGENE THERAPEUTICS, INC.
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO CA 94080
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Revolution Medicines, Inc. 0001628171 2020-06-17 director
RELMADA THERAPEUTICS, INC. 0001553643 2019-12-19 director
Allogene Therapeutics, Inc. 0001737287 2018-10-10 officer: Chief Financial Officer


Items 1 - 71

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2023-06-08   Revolution Medicines, Inc. 4 A-Award --D 18400.0000 18400.0000 2 0001628171 Stock Option (Right to Buy)
A 2023-06-08   Revolution Medicines, Inc. 4 A-Award --D 5200.0000 21251.0000 1 0001628171 Common Stock
A 2023-05-25   RELMADA THERAPEUTICS, INC. 4 A-Award --D 92958.0000 150000.0000 1 0001553643 Stock Option (right to buy)
A 2023-03-22   Allogene Therapeutics, Inc. 4 A-Award --D 432738.0000 432738.0000 3 0001737287 Stock Option (Right to Buy)
A 2023-03-22   Allogene Therapeutics, Inc. 4 A-Award --D 558094.0000 862439.0000 1 0001737287 Common Stock
D 2023-03-14   Allogene Therapeutics, Inc. 4 F-InKind --D 35879.0000 304345.0000 1 0001737287 Common Stock
A 2022-12-16   RELMADA THERAPEUTICS, INC. 4 A-Award --D 57042.0000 57042.0000 1 0001553643 Stock Option (right to buy)
A 2022-06-16   Revolution Medicines, Inc. 4 A-Award --D 18400.0000 18400.0000 2 0001628171 Stock Option (Right to Buy)
A 2022-06-16   Revolution Medicines, Inc. 4 A-Award --D 5200.0000 16051.0000 1 0001628171 Common Stock
A 2022-05-25   RELMADA THERAPEUTICS, INC. 4 A-Award --D 91235.0000 150000.0000 1 0001553643 Stock Option (right to buy)
A 2022-03-23   Allogene Therapeutics, Inc. 4 A-Award --D 368589.0000 368589.0000 3 0001737287 Stock Option (Right to Buy)
A 2022-03-23   Allogene Therapeutics, Inc. 4 A-Award --D 237358.0000 337904.0000 1 0001737287 Common Stock
D 2022-03-15   Allogene Therapeutics, Inc. 4 S-Sale --D 11469.0000 100546.0000 1 0001737287 Common Stock
A 2021-12-17   RELMADA THERAPEUTICS, INC. 4 A-Award --D 58765.0000 58765.0000 1 0001553643 Stock Option (right to buy)
A 2021-06-22   Revolution Medicines, Inc. 4 A-Award --D 12659.0000 12659.0000 2 0001628171 Stock Option (Right to Buy)
A 2021-06-22   Revolution Medicines, Inc. 4 A-Award --D 3617.0000 10851.0000 1 0001628171 Common Stock
D 2021-05-24   Allogene Therapeutics, Inc. 4 M-Exempt --D 14897.0000 94703.0000 3 0001737287 Stock Option (Right to Buy)
A 2021-05-24   Allogene Therapeutics, Inc. 4 M-Exempt --D 14897.0000 110994.0000 1 0001737287 Common Stock
A 2021-03-26   Allogene Therapeutics, Inc. 4 A-Award --D 92365.0000 92365.0000 3 0001737287 Stock Option (Right to Buy)
A 2021-03-26   Allogene Therapeutics, Inc. 4 A-Award --D 24866.0000 96097.0000 1 0001737287 Common Stock
D 2021-03-15   Allogene Therapeutics, Inc. 4 S-Sale --D 8053.0000 71231.0000 1 0001737287 Common Stock
D 2021-01-15   Allogene Therapeutics, Inc. 4 S-Sale --I 3547.0000 1164048.0000 3 0001737287 Common Stock
D 2021-01-15   Allogene Therapeutics, Inc. 4 S-Sale --I 11053.0000 1152995.0000 4 0001737287 Common Stock
D 2021-01-15   Allogene Therapeutics, Inc. 4 S-Sale --I 400.0000 1152595.0000 5 0001737287 Common Stock
D 2021-01-14   Allogene Therapeutics, Inc. 4 S-Sale --I 9851.0000 1172744.0000 1 0001737287 Common Stock
D 2021-01-14   Allogene Therapeutics, Inc. 4 S-Sale --I 5149.0000 1167595.0000 2 0001737287 Common Stock
A 2021-01-07   RELMADA THERAPEUTICS, INC. 4 A-Award --D 100000.0000 100000.0000 1 0001553643 Options to purchase common stock
D 2020-11-16   Allogene Therapeutics, Inc. 4 S-Sale --I 4634.0000 1192961.0000 1 0001737287 Common Stock
D 2020-11-16   Allogene Therapeutics, Inc. 4 S-Sale --I 10366.0000 1182595.0000 2 0001737287 Common Stock
D 2020-10-15   Allogene Therapeutics, Inc. 4 S-Sale --I 5104.0000 1207491.0000 1 0001737287 Common Stock
D 2020-10-15   Allogene Therapeutics, Inc. 4 S-Sale --I 4218.0000 1203273.0000 2 0001737287 Common Stock
D 2020-10-15   Allogene Therapeutics, Inc. 4 S-Sale --I 3479.0000 1199794.0000 3 0001737287 Common Stock
D 2020-10-15   Allogene Therapeutics, Inc. 4 S-Sale --I 2099.0000 1197695.0000 4 0001737287 Common Stock
D 2020-10-15   Allogene Therapeutics, Inc. 4 S-Sale --I 100.0000 1197595.0000 5 0001737287 Common Stock
D 2020-09-21   Allogene Therapeutics, Inc. 4 S-Sale --I 3200.0000 1214506.0000 2 0001737287 Common Stock
D 2020-09-21   Allogene Therapeutics, Inc. 4 S-Sale --I 1911.0000 1212595.0000 3 0001737287 Common Stock
D 2020-09-21   Allogene Therapeutics, Inc. 4 S-Sale --I 9889.0000 1217706.0000 1 0001737287 Common Stock
A 2020-06-17   Revolution Medicines, Inc. 4 A-Award --D 25318.0000 25318.0000 2 0001628171 Stock Option (Right to Buy)
A 2020-06-17   Revolution Medicines, Inc. 4 A-Award --D 7234.0000 7234.0000 1 0001628171 Common Stock
D 2020-04-09   RELMADA THERAPEUTICS, INC. 4 X-InTheMoney --D 12500.0000 0.0000 4 0001553643 Warrants to purchase common stock
A 2020-04-09   RELMADA THERAPEUTICS, INC. 4 X-InTheMoney --D 32500.0000 87500.0000 1 0001553643 Common Stock
A 2020-04-09   RELMADA THERAPEUTICS, INC. 4 X-InTheMoney --D 12500.0000 100000.0000 2 0001553643 Common Stock
D 2020-04-09   RELMADA THERAPEUTICS, INC. 4 X-InTheMoney --D 32500.0000 0.0000 3 0001553643 Warrants to purchase common stock
A 2020-03-18   Allogene Therapeutics, Inc. 4 A-Award --D 30800.0000 78706.0000 1 0001737287 Common Stock
A 2020-03-18   Allogene Therapeutics, Inc. 4 A-Award --D 109600.0000 109600.0000 3 0001737287 Stock Option (Right to Buy)
D 2020-03-16   Allogene Therapeutics, Inc. 4 S-Sale --D 300.0000 47906.0000 2 0001737287 Common Stock
D 2020-03-16   Allogene Therapeutics, Inc. 4 S-Sale --D 5150.0000 47257.0000 1 0001737287 Common Stock
D 2020-02-20   Allogene Therapeutics, Inc. 4 J-Other --I 237155.0000 1227595.0000 2 0001737287 Common Stock
A 2019-03-13   Allogene Therapeutics, Inc. 4 A-Award --D 49400.0000 49400.0000 1 0001737287 Common Stock
A 2019-03-13   Allogene Therapeutics, Inc. 4 A-Award --D 83500.0000 83500.0000 3 0001737287 Employee Stock Option (Right to Buy)
- -   Allogene Therapeutics, Inc. 4 - --I 1227595.0000 3 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 3 - --I 1464750.0000 1 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1464750.0000 2 0001737287 Common Stock
- -   RELMADA THERAPEUTICS, INC. 3 - --D 55000.0000 1 0001553643 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   RELMADA THERAPEUTICS, INC. 3 - --D 2 0001553643 Options to purchase common stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   RELMADA THERAPEUTICS, INC. 3 - --D 3 0001553643 Options to purchase common stock
- -   RELMADA THERAPEUTICS, INC. 3 - --D 4 0001553643 Options to purchase common stock
- -   Allogene Therapeutics, Inc. 4 - --D 52407.0000 1 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1227595.0000 2 0001737287 Common Stock
- -   Revolution Medicines, Inc. 3 - --- 1 - -
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --D 79146.0000 4 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --D 78916.0000 6 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --D 78916.0000 3 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --D 78916.0000 6 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock
- -   Allogene Therapeutics, Inc. 4 - --I 1152595.0000 2 0001737287 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016